Tumor microenvironment in prostate cancer: toward identification of novel molecular biomarkers for diagnosis, prognosis, and therapy development

HF Bahmad, M Jalloul, J Azar, MM Moubarak… - Frontiers in …, 2021 - frontiersin.org
Prostate cancer (PCa) is by far the most commonly diagnosed cancer in men worldwide.
Despite sensitivity to androgen deprivation, patients with advanced disease eventually …

Dietary polyphenols: Extraction, identification, bioavailability, and role for prevention and treatment of colorectal and prostate cancers

N Ahmad, M Qamar, Y Yuan, Y Nazir, P Wilairatana… - Molecules, 2022 - mdpi.com
Fruits, vegetables, and other edible plants in our diet have numerous health benefits, due to
the bioactive compounds in these food items, including polyphenols. These plants are a rich …

Development of (−)-epigallocatechin-3-gallate-loaded folate receptor-targeted nanoparticles for prostate cancer treatment

RF Alserihi, MRS Mohammed, M Kaleem… - Nanotechnology …, 2021 - degruyter.com
In continuation of our previous studies, we developed polymeric epigallocatechin 3-gallate
(EGCG)-loaded nanoparticles (NPs) coupled with folic acid (FA), able to dually bind the …

Recent advances and future perspectives in the therapeutics of prostate cancer

GL Varaprasad, VK Gupta, K Prasad, E Kim… - … Hematology & Oncology, 2023 - Springer
Prostate cancer (PC) is one of the most common cancers in males and the fifth leading
reason of death. Age, ethnicity, family history, and genetic defects are major factors that …

Sex differences associated with adverse drug reactions resulting in hospital admissions

LC Hendriksen, PD van der Linden… - Biology of sex …, 2021 - Springer
Background Adverse drug events, including adverse drug reactions (ADRs), are responsible
for approximately 5% of unplanned hospital admissions: a major health concern. Women …

Gefitinib: an updated review of its role in the cancer management, its nanotechnological interventions, recent patents and clinical trials

P Kumar, B Mangla, S Javed, W Ahsan… - Recent patents on …, 2023 - ingentaconnect.com
Background: Gefitinib, a tyrosine kinase inhibitor, is effectively used in the targeted treatment
of malignant conditions. It suppresses the signal transduction cascades leading to cell …

[HTML][HTML] Advances in nanomaterial-based immunosensors for prostate cancer screening

R Khan, F Arshad, IU Hassan, GA Naikoo… - Biomedicine & …, 2022 - Elsevier
Prostate cancer is one of the most common health hazards for men worldwide, specifically in
Western countries. Rapid prostate cancer screening by analyzing the prostate-specific …

Knowledge and attitudes towards prostate cancer and screening among males in limpopo province, South Africa

N Maladze, A Maphula, M Maluleke… - International Journal of …, 2023 - mdpi.com
Inadequate knowledge and poor attitudes about prostate cancer (PC) negatively affect early
screening practices among males. The PC mortality rate is increasing due to late reporting …

Autophagy, a critical element in the aging male reproductive disorders and prostate cancer: a therapeutic point of view

P Raee, SC Tan, S Najafi, F Zandsalimi, TY Low… - Reproductive Biology …, 2023 - Springer
Autophagy is a highly conserved, lysosome-dependent biological mechanism involved in
the degradation and recycling of cellular components. There is growing evidence that …

Anticancer activity of selenium nanoparticles in vitro studies

F Martínez-Esquivias… - Anti-Cancer Agents …, 2022 - ingentaconnect.com
Health systems worldwide consider cancer a disease that causes the highest number of
deaths per year. The low efficacy of current cancer therapies has led other areas of science …